MINI FUTURE LONG - STRYKER CORP. Stock

Certificat

DE000PH7AVN7

Delayed Deutsche Boerse AG 13:50:33 2024-07-01 EDT
15.61 EUR -1.82% Intraday chart for MINI FUTURE LONG - STRYKER CORP.
Current month+1.21%
1 month+1.40%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-01 15.61 -1.82%
24-06-28 15.9 -0.38%
24-06-27 15.96 -0.31%
24-06-26 16.01 +1.65%
24-06-25 15.75 -0.57%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 01:50 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH7AVN
ISINDE000PH7AVN7
Date issued 2021-11-19
Strike 169.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 10.77
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 18.05
Lowest since issue 4.48
Spread 0.03
Spread %0.19%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus